FDA OKs New Wearable Treatment for Parkinson's Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday. The wearable device is the first subcutaneous apomorphine infusion device for Parkinson's and provides continuous treatment during the day, Supernus noted.
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday. Shares of the company were up 5% in early trading.
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump Onapgo
Three strikes and you’re out? Not for Supernus and its Parkinson’s disease infusion pump. | The device is meant to allow patients more control over their "Off" time, or the instances when medicine wears off and symptoms return or worsen.
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion device that provides continuous treatment during the waking day for more consistent control of OFF timeONAPGO will be available in the U.
Supernus stock surges on FDA approval
Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ONAPGO for the treatment of motor fluctuations in adults with advanced Parkinson's disease.
Supernus stock climbs 5% on FDA approval of Onapgo
Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) rose 5% Tuesday morning on news the FDA has approved its wearable treatment device Onapgo, formerly known as SPN-830, for the treatment of patients with Parkinson's disease.
WPLG3h
New procedure can be life changing for people suffering from Parkinson's
Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...
The link between renal failure and Parkinson's disease: Researchers illuminate the underlying mechanisms
Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...
Grammys winner for ‘Best New Artist’ in the 90s reveals Parkinson’s diagnosis, wants to continue performing ‘as long as possible’
The singer-songwriter gained recognition from the Recording Academy in the early 1990s, winning the Grammy for Best New ...
‘Walking in Memphis’ singer Marc Cohn reveals years-long Parkinson’s battle: ‘Needed time to process’
Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...
GLP-1 drug shows little benefit for people with Parkinson's disease, trial finds
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
Rolling Out5d
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Grammy-winning singer, Cleveland native reveals Parkinson’s diagnosis
Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...
Friends unite to fight Parkinson's Disease with free Massive Open Online Course
Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...